India's top drug regulator cited insufficient evidence of efficacy in the two studies conducted by Serum Institute and ICMR.

About 1 in 4 American adults got a covid vaccine shot during the 2024-25 virus season, a fraction health care experts warn ...

An alleged extortion attempt, a petty yearslong grudge, shocking social media posts, and ominous text messages make up the ...

Natasha Smith has seen her views on vaccines transform. “I had been reading books about pregnancy and parenthood of toddlers, ...

Despite the muted success of Sanofi's Dengvaxia in the global market, Globaldata analysts forecast a rosy outlook for Qdenga.

Through his leadership at the FDA's Center for Biologics Evaluation and Research (CBER), Vinay Prasad, MD, MPH has pushed out at least 7 senior leaders and created an environment that employees worry ...

"This is very exciting," says one infectious disease doctor. The new RSV vaccines were approved in 2023—and today’s research ...

The Peter Kim Lab was recently awarded $18 million by the Coalition for Epidemic Preparedness to create a vaccine to protect ...

Dr. Vinay Prasad, who oversees FDA’s vaccine and biologics center, resigned in July after coming under fire from conservative ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

On August 22, 2025, the U.S. Food and Drug Administration’s Center for Biologics Evaluation and Research (CBER) suspended the biologics license for IXCHIQ, a live-attenuated chikungunya vaccine, ...

Shares of Pfizer Inc. gave up ground in early Tuesday trading, after the drug giant reported a decline in revenue, as ...